Aerosolized MMR vaccine: evaluating potential transmission of components to vaccine administrators and contacts of vaccinees.

Although numerous operative and immunological advantages accompany aerosol immunization, potential vaccine virus transmission from the aerosol device to vaccine administrators or from aerosol vaccinees to their contacts requires further study. We conducted a clinical and serological follow-up study of vaccine administrators and matched classroom or household contacts of young adults who received the MMR vaccines by aerosol or injection. Differences in incidence of clinical adverse events between vaccinees and contacts were not statistically significant. No seroresponses to any components of MMR vaccine were noted among 25 matched contacts of persons receiving injected vaccines, and only one equivocal seroresponse was noted among 25 matched contacts of aerosol recipients. No seroresponses were observed in 3 persons who administered aerosol vaccine. The composite findings of this study provide additional evidence of the safety of this approach. Copyright © 2012 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.

Citation

Jose-Luis Diaz-Ortega, John V Bennett, Deyanira Castaneda, David Martinez, Jorge Fernandez de Castro. Aerosolized MMR vaccine: evaluating potential transmission of components to vaccine administrators and contacts of vaccinees. Biologicals : journal of the International Association of Biological Standardization. 2012 Jul;40(4):278-81

Mesh Tags

Substances

PMID: 22494953

search → result